The Company did not borrow any funds during the last two fiscal years.
Net income for the nine months ended March 31, 2019, was $1,201,886 or $0.51 and $0.50 per share, basic and diluted, respectively compared to $2,375,399 or $1.02 per share, basic and diluted, for the nine months ended March 31, 2018.
During the nine months ended March 31, 2019 and 2018, the Company expended $538,550 and $632,023, respectively, for plant improvements and new equipment.
This report contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
The Company's sales do not represent a significant share of the industry's market for any class of its products.
In order to maintain a balanced business, we are continuing to place an emphasis on securing “build to print” opportunities, which will allow production work to go directly to the manufacturing floor, limiting the impact on our engineering staff.
The Company has budgeted approximately $750,000 for new equipment and plant improvements in fiscal year 2019.
In the case of the latter, the Company can incur what it refers to as “loss contracts,” meaning engineering design contracts in which the Company invests with the objective of developing future product sales.
The Company’s effective tax rates for the three and nine months ended March 31, 2019, were 18.1% and 17.7%, respectively, compared to 23.6% and 25.2% for the three and nine months ended March 31, 2018.
In order to maintain a balanced business, we are continuing to place an emphasis on securing “build to print” opportunities, which will allow production work to go directly to the manufacturing floor, limiting the impact on our engineering staff.
 (1)Pursuant to a prior Board of Directors authorization, as of March 31, 2019 the Company can repurchase up to $876,297 of its common stock pursuant to an ongoing plan.
Management has available a $3,000,000 line of credit to help fund further growth or working capital needs, if necessary, but does not anticipate the need for any borrowed funds in the foreseeable future.
The increase in cash used in financing activities in the current period is primarily related to the cash expended for the special dividend totaling $1.00 per share declared and paid in fiscal 2019 offset, in part, by proceeds received from the exercise of stock options during the current fiscal year.
Selling, general and administrative expenses were $3,374,301 for the nine months ended March 31, 2019; an increase of $617,982 compared to the nine months ended March 31, 2018.
The minimum of $12.2 million does not include any shipments, which may be made against orders subsequently received during the fiscal year ending June 30, 2019.
When making this determination, we consider factors such as whether two or more contracts were negotiated and executed at or near the same time, or were negotiated with an overall profit objective. 31.1Certification of the Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.